Ruben A. Mesa, MD of Mayo Clinic explains the importance of the NCCN and its development of new guidelines for…
Browsing: Acute Lymphoblastic Leukemia
Ruben A. Mesa, MD of Mayo Clinic gives an overview of the new guidelines that are set for leukemia. He…
Saketh Guntupalli, MD of University of Colorado School of Medicine gives an overview of the kinds of treatment trends for…
Saketh Guntupalli, MD of University of Colorado School of Medicine explains how patients were picked for his clinical study and…
Saketh Guntupalli, MD of University of Colorado School of Medicine discusses the importance of his study and how he hopes…
Saketh Guntupalli, MD of University of Colorado School of Medicine gives his take on how women can deal with their…
Saketh Guntupalli, MD of University of Colorado School of Medicine discusses interesting topics that were discussed at the 2017 Society…
Saketh Guntupalli, MD of University of Colorado School of Medicine discusses the data of his presentation, which was a randomized…
Thomas Powles, MBBS, MRCP, MD, from the Barts Cancer Institute, London, UK, gives an overview of the KEYNOTE-052 (NCT02335424) trial…
Peter Albers, MD, from the Heinrich-Heine-University Düsseldorf, Germany, discusses the concept of a semi-live surgical masterclass at the European Association…
Maurizio Brausi, MD, from the AUSL Modena, B. Ramazzini Hospital, Modena, Italy, discusses the use of robotic surgery for urological…
Jochen Walz, MD, from the Paoli-Calmettes Institute, Marseille, France, discusses the use of magnetic resonance imaging (MRI) in targeting prostate…
Joaquim Bellmunt, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, discusses recent advances in treating genitourinary malignancies at the…
From our MPN Ask the Expert series, Patient Power viewer, Barb, asks a question about peripheral neuropathy as a side…
Susan C. Modesitt, MD of University of Virginia Health System gives an overview the hot topics and trends that were…
Susan C. Modesitt, MD of University of Virginia Health System discusses the treatment of sentinel lymph nodes, which unintentionally cause…
Susan C. Modesitt, MD of University of Virginia Health System explains whether or not hospital readmission is an appropriate marker…
Susan C. Modesitt, MD of University of Virginia Health System discusses the use of PARP inhibitors and their benefits towards…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses how the use of PARP Inhibitors work for Ovarian Cancer…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses the use of PARP Inhibitors and in combination with Anti-VEGF,…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC explains why the use of molecular analysis to determine therapy choice…
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses novel agents, Olaparib and Rucaparib, that target BRCA mutations in…
Don Dizon, MD of Massachusetts General Hospital discusses data that argued how platinum sensitivity was an important predictor for Rucaparib…
Don Dizon, MD of Massachusetts General Hospital gives an overview of the treatment trends for 2017 in ovarian cancer treatment,…
Don Dizon, MD of Massachusetts General Hospital gives an overview of the SOLO2 Trial and the use of olaparib in…
Don Dizon, MD of Massachusetts General Hospital discusses the use of novel agents in ovarian cancer. He states that Olaparib…
Don Dizon, MD of Massachusetts General Hospital discusses the use of immunotherapy in cervical cancer treatment. He explains a clinical…
Learn more about personalized medicine, also known as precision medicine, in this web interview with Patient Power Host Andrew Schorr…
Christina Annunziata, MD, PhD of National Institutes of Health discusses how some novel agents may meet the guidelines for accelerated…
Christina Annunziata, MD, PhD of National Institutes of Health explains how the phase 2-3 design decreases the number of patients…
Christina Annunziata, MD, PhD of National Institutes of Health discusses how to take a drug from phase 1 to phase…
Christina Annunziata, MD, PhD of National Institutes of Health discusses how future research will be affected by clinical trials. She…
MPN experts, Dr. Michael Grunwald from Carolinas HealthCare System’s Levine Cancer Institute and Dr. Srdan Verstovsek from The University of…
Philip McCarthy, MD, Director of the Blood and Marrow Transplant Center at Roswell Park Cancer Institute in Buffalo, NY, shares…
Amrita Krishnan, MD FACP Director, Professor of Hematology/Hematopoietic Cell Transplantation gives an update to Multiple Myeloma Research at the MOASC…
Przemyslaw Twardowski, M.D., Clinical Professor of Medical Oncology, Director, Genitourinary Oncology, City of Hope Cancer Center and David Quinn, MBBS.,…
Sybil R. Green, JD, RPh, MHA talks about MACRA Rules are Final: Time to Implement the Quality Payment Program at…
James Suh, MD, Senior Pathologist and Associate Medical Director, Laboratory Director, Research Triangle Park, NC discusses the Comprehensive Genomic Profiling:…
At a recent MPN town meeting, Dr. Jigar Trivedi, Clinical Pharmacist Coordinator, Department of Pharmacy at Carolinas HealthCare System’s Levine…
David Spetzler, PhD, President and Chief Scientific Officer, Caris Life Sciences discusses Caris Molecular Intelligence® Evidence-Guided Molecular Analysis Services at…
Karen Reckamp, MD, Medical Director, Clinical Research, City of Hope Comprehensive Cancer Center discusses The Role of Utilizing Next Generation…
Edward B. Garon, MD, MS, Director of Thoracic Oncology, David Geffen School of Medicine at UCLA discusses Personalizing lung cancer…
In this presentation from Lymphoma & Myeloma 2016, Dr. Robert W. Chen argues in favor of the use of allogeneic…
In this presentation from Lymphoma & Myeloma 2016, Dr. Alison Moskowitz argues in favor of the use of serial novel…
In this presentation from Lymphoma & Myeloma 2016, Dr. Koen van Besien argues for stem cell transplant-based therapy in the…
In this presentation from Lymphoma & Myeloma 2016, Dr. Ann S. LaCasce argues for radion therapy in the treatment of…
In this presentation from Lymphoma & Myeloma 2016, Dr. Leandro Cerchietti discusses novel therapeutic strategies for B cell lymphomas. Click…
In this presentation from Lymphoma & Myeloma 2016, Dr. David Weinstock discusses new targets in peripheral T cell lymphomas. Click…
In this presentation from Lymphoma & Myeloma 2016, Dr. Steven Treon discusses new insights into the biology and treatment of…